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Conclusions: The intrafractional motion was not reduced due 
to the reduction in treatment time. 
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Purpose/Objective: Stereotactic treatments require high 
geometrical accuracy of the whole treatment chain to safely 
deposit the dose in the tumor while sparing the healthy 
tissue. Modern linear accelerators perform radiosurgery (SRS) 
treatments with sub-millimeter accuracy in dose delivery, as 
well as image guided patient setup. However, intra-fractional 
patient motion is a source of uncertainty in these 
treatments. The feasibility of using the Calypso (Varian, USA) 
radiofrequency tracking system for intra-fractional motion 
monitoring during cranial SRS treatments was evaluated. 
Materials and Methods: Studies were performed using the 
Calypso system with the wireless surface transponder that 
consists of 2 orthogonally connected electromagnetic 
resonance circuits. A magnetic source and receiver coil array 
are used to determine the transponders’ positions. The 
electromagnetic array is tracked in real time relative to the 
isocenter through the use of an infrared optical-tracking 
system. For the measurement, the Alderson head phantom 
was used and 3 volunteers participated in the studies. The 
Calypso surface transponders were positioned with a sticky 
tape behind the ear, close to the auricle of the phantom and 
volunteers. Accuracy of couch shifts and couch rotations 
were evaluated and compared to results from optical surface 
monitoring system (OSMS, Varian, USA). As the Calypso 
tracking volume is limited to a cylinder with 9 cm radius, a 
height of 21 cm and center of mass at the isocenter, 
additional feasibility of placing the transponders behind the 
ear was retrospectively evaluated from CT scans of 40 
intracranial tumor volumes previously treated in our clinic. 
Results: The use of Calypso is limited to 120° of couch 
rotations due to the Calypso console that needs to be placed 
next to the couch and the finite length of the antenna arm. 
Calypso detected couch shifts with an accuracy of 0.18 
(±0.12) mm, 0.14 (±0.12) mm, 0.11 (±0.08) mm in vertical, 
longitudinal and lateral directions respectively with respect 
to OSMS. The rotational isocenter run-out was 0.43 (±0.23) 
mm. On volunteers the 3D deviation between Calypso and 
OSMS was 1.38 (±0.68) mm mainly due to the time delay of 
about 10 s between Calypso and OSMS measurements in 
which the volunteer could move. Out of the 40 intracranial 
tumor volumes, 36 were in the tracking cylinder of Calypso 
and would therefore be feasible to treat with the system. 
Conclusions: Intra-fractional motion can be monitored using 
the Calypso system with an accuracy of less than 1 mm 
necessary for the SRS treatments. The volunteer studies 
showed the possibility of using the Calypso surface 
transponder positioned behind the ear for the stereotactic 
treatments. 90% of the studied intracranial patients would 
qualify for the SRS treatment using Calypso.  
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Purpose/Objective: The purpose of this study was to 
evaluate and compare enhanced inspiration gating (EIG) and 
deep inspiration breath hold (DIBH), with and without visual 
guidance. The study also included pressure measurements to 
investigate the potential risk of patient lifting during DIBH. 
Materials and Methods: Twenty healthy female volunteers 
were included in the study. The volunteers performed both 
EIG and DIBH, with and without visual guidance. Based on a 
practice session a 3 mm gating window was introduced at an 
individual amplitude for both EIG and DIBH. To monitor the 
breathing and to have access to visual guidance the Catalyst 
(C-RAD positioning AB, Uppsala, Sweden) was used. 
Parameters such as reproducibility, stability and the 
percentage attendance in the gating window (PGW) were 
evaluated. The study also included pressure measurements 
with the I-scan system and sensor model 9801 (Tekscan Inc., 
South Boston, USA) which was placed under the patients 
scapulas. These novel pressure measurements were used to 
evaluate any potential risk of patient lifting to enter the 
gating window during DIBH, and thus not increasing the 
spatial distance between the heart and the target volume. 
The last step in the study was to investigate how long time 
the volunteers were able to hold their breath in the gating 
window.  
Results: Spontaneously, without visual guidance, the 
volunteers breathed significantly deeper using DIBH 
compared to EIG, and thus potentially increased the distance 
between the heart and the target volume. The average chest 
amplitude for EIG was 10.8 ± 4.7 mm (1 SD) and for DIBH 12.9 
± 5.8 mm. The reproducibility and PGW improved for both 
techniques when visual guidance was added. The stability did 
not indicate any particular trend. The pressure 
measurements showed that there was a possible risk that the 
volunteers lifted from the couch during DIBH, which was 
more prominent for high amplitudes (~2.5 cm) and when 
visual guidance was used. On average the volunteers where 
able to hold their breath for 57.2 ± 22.5 s. 
Conclusions: According to this study there are major 
advantages using DIBH and visual guidance. DIBH resulted in 
higher amplitudes which could result in sparing of cardiac 
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and pulmonary dose. To prevent patient lifting, patients 
should not be pushed to perform too high amplitudes. There 
are no benefits regarding reproducibility, stability and PGW of 
changing gating method from EIG to DIBH if no visual 
guidance can be provided.  
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Purpose/Objective: For volumetric modulated arc therapy-
stereotactic body radiation therapy (VMAT-SBRT), in-
treatment four-dimensional cone-beam CT (4D CBCT) images 
are the most reliable tool for evaluating setup error and the 
intrafractional location of the moving target. We established 
and updated a novel verification system and quantitatively 
assessed the accuracy of our VMAT-SBRT delivery through the 
use of it. 
Materials and Methods: Five patients undergoing VMAT-SBRT 
at our hospital were included in this analysis. All patients had 
stage I non-small cell lung cancer or single lesion 
oligometastatic lung tumors. In the supine position, an 
abdominal compressor and the Elekta stereotactic body 
frame were used. The gross tumor volumes (GTVs) were 
contoured on all 10 phases of the 4D planning CT. GTVs were 
merged into the internal target volume (ITV). The planning 
target volume (PTV) was created by adding a 5 mm margin to 
the ITV in all directions. Fifty-five Gy in 4 fractions was 
prescribed to cover 95% of the PTV. Before each treatment, 
registration was manually performed using pre-treatment 4D 
CBCT with the Elekta XVI system, v4.5 or v5.0. During each 
fraction, in-treatment 4D CBCT images, subdivided into 10 
phases were obtained and exported to Pinnacle3. The 
respective tumor locations during beam delivery, as 
determined with the 4D CBCT, were merged to form the 
'actual ITV.' We could then evaluate discrepancies between 
the 'actual ITV' and the planning ITV. To assess the adequacy 
of the PTV margin, we also analyzed whether PTV covered 
the 'actual ITV' completely. 
 
 
 
Results: From the 5 patients, 200 4D CBCT image sets taken 
during VMAT-SBRT were successfully obtained and the 
intrafractional tumor motions during beam delivery were 
reasonably reproduced. Under suppressed respiration, the 
average amplitude of tumor motion was 4.2±3.0mm in the 
cranio-caudal direction. On average, the 'actual ITV' covered 
87.2±5.6% of the planning ITV. In addition, the respective 
PTV encompassed all tumor locations in all phases. 
Conclusions: By using in-treatment 4D CBCT, we proved the 
adequacy of our ITV-PTV margin setting for VMAT-SBRT when 
the registration for moving lung tumors was performed using 
pre-treatment 4D CBCT. This result also provides valuable 
information prior to starting adaptive SBRT for lung tumors.   
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Purpose/Objective: Internal intra-fraction motion during 
radiotherapy can result in sub-optimal treatment delivery 
and thus real-time adaptation strategies such as MLC tracking 
or gating are currently being investigated in the clinic. The 
goal of this study is to investigate the dosimetric effect of 
gated prostate cancer radiotherapy utilising kilovoltage 
intrafraction monitoring (KIM) in the first prospective clinical 
trial. In KIM, prostate position monitoring by kV flouroscopy is 
used to gate off the beam and re-position the patient if the 
prostate moves outside a predefine region. 
Materials and Methods: KIM is being evaluated for real-time 
target localisation in a 30-patient prostate radiotherapy trial. 
So far, one patient has completed the 40 fraction treatment, 
and another two patients are currently undergoing 
treatment. The dose delivered during each fraction with KIM 
was calculated using an isocenter shift dose reconstruction 
method. For the fractions where a gating event (with motion 
exceeding 3mm for 5 seconds) occurred, dose calculation was 
also performed for a simulated treatment scenario with no 
KIM gating correction. Dosimetric impact of KIM gating was 
evaluated through comparison of target and normal tissue 
dose volume statistics for the planned treatment delivery, 
delivery with KIM gating and delivery with no KIM correction 
(see Figure 1), for each of the gated fractions. 
Results: In this preliminary work, all fractions from the first 
patient’s treatment were studied. Four fractions (out of 40) 
had successful KIM gating corrections. Prostate motion (mean 
± standard deviation) with KIM corrections and simulated 
with no KIM corrections were 2.2±1.4 mm and 4.1±0.7 mm 
respectively. Ranges of differences between the planned and 
KIM corrected doses and the planned and no KIM correction 
doses were respectively: PTV D95% (-2.75, -0.26) & (-4.29, -
2.27); CTV D100% (-2.41, -0.06) & (-0.95, 0.31); rectum V65% 
(-2.30, -0.48) & (-6.09,-3.20); and bladder V65% (-0.86, 0.50) 
& (-1.02, 1.72). In these fractions, PTV V105% was higher 
than the planned value with both KIM gating (2.98-22.18%) 
and with no KIM correction (17.16-27.25%). It should be noted 
